Ridgeview Clinics offer OneOme RightMed™ test

Learn more by calling Ridgeview Chaska Clinic at 952-361-2450

The RightMed™ test developed by OneOme, is a cost-effective, comprehensive, and clinically actionable pharmacogenomic test covering 22 genes, which can be provided as part of routine clinical care. Pharmacogenomics is the study of how genes affect a person's response to drugs. The relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses tailored to a person's genetic makeup. RightMed health care providers make timely, evidenced-based, personalized prescription treatment decisions for more than 340 medications.

The cheek-swab test is available to Ridgeview Clinic patients at select sites for $350; however, those who may benefit most include: those who take some classes of medication, such as cardiovascular prescriptions; those who are struggling with adverse drug reactions, unwanted side effects, medications that are not working; or those who are on multiple medications.

Studies show that approximately 50 percent of the four billion prescriptions issued each year in the U.S. do not work as intended for patients. In addition, adverse drug reactions account for seven percent of hospital admissions and 20 percent of readmissions nationwide. The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmocogenomics into routine clinical care. OneOme is a privately held company backed by early-stage venture firm Invenshure, LLC, and Mayo Clinic.

To schedule an appointment for a RightMed test, call Ridgeview Chaska Clinic at 952-361-2450.

For more information about RightMed, visit www.oneome.com


New Call-to-action